Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer

Journal of Thoracic Oncology

Volumn 4, Issue 1, 2009, Pages 139-141

  Prudkin, Ludmila ^a   Tang, Ximing ^a   Wistuba, Ignacio I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; EGFR PROTEIN, HUMAN; PRIMER DNA; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID COMPOSITION; BLOOD SAMPLING; BRONCHUS MUCOSA; CANCER SUSCEPTIBILITY; CASE REPORT; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GERM LINE; HUMAN; LETTER; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; NEUROENDOCRINE TUMOR; PERIPHERAL BLOOD MONONUCLEAR CELL; POINT MUTATION; PRIORITY JOURNAL; SOMATIC CELL; T790M GENE; TUMOR BIOPSY; ADENOCARCINOMA; CANCER INVASION; CARCINOMA; GENETICS; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PEDIGREE;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; DNA PRIMERS; FEMALE; GERM-LINE MUTATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PEDIGREE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 61549124759     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181915f92     Document Type: Letter

References (7)

1. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346.
2. Pao W, Miller VA, Politi KA, et al. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Sec- ond Mutation in the EGFR Kinase Domain. PLoS Med 2005;2:1-11.
3. Kobayashi S, Boggon TJ, Dayaram T, et al. EGFR mutation and resistance of non-smallcell lung cancer to gefitinib. N Engl J Med 2005;352:786-792.
4. Bell DW, Gore I, Okimoto RA, et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet 2005;37: 1315-1316.
5. Inukai M, Toyooka S, Ito S, et al. Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. Cancer Res 2006;66:7854-7858.
6. Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005;65:7568-7572.
7. Vikis H, Sato M, James M, et al. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res 2007;67:4665-4670.